
Analysis of Some Immunogenic Properties of the Recombinant Sporothrix Schenckii Gp70 Expressed in Escherichia Coli
2019; Future Medicine; Volume: 14; Issue: 5 Linguagem: Inglês
10.2217/fmb-2018-0295
ISSN1746-0921
AutoresJosé A. Martínez-Álvarez, Laura C. García-Carnero, Paula Kubitschek-Barreira, Nancy E. Lozoya‐Pérez, José L. Belmonte‐Vázquez, José RF de Almeida, Antonio Gómez-Infante, Nathália Curty, Julio C. Villagómez‐Castro, Eduardo Peña‐Cabrera, Iván Martínez-Duncker, Sandro Rogério de Almeida, Leila M. Lopes‐Bezerra, Héctor M. Mora‐Montes,
Tópico(s)Galectins and Cancer Biology
ResumoAim: Sporothrix schenckii is the causative agent of sporotrichosis. A 70-kDa glycoprotein, Gp70, is a candidate for the development of prophylactic alternatives to control the disease, and its gene (GP70) is predicted to encode for a protein of 43 kDa, contrasting with the molecular weight of the native protein. Materials & methods: The GP70 was expressed in bacteria, the recombinant protein purified, used in immunoassays and injected to Galleria mellonella. Results & conclusion: The recombinant protein was detected by anti-Gp70 antibodies, confirming that the Gp70 backbone is a 43-kDa peptide. This protein showed enzyme activity of cyclase and was recognized by sera of patients with sporotrichosis. Although it was not useful for serodiagnosis of sporotrichosis, it conferred protection to animals against experimental sporotrichosis.
Referência(s)